Abstract | PURPOSE: Our purpose of this study was to evaluate the effect of a transdermal estradiol delivery system in postmenopausal women with confirmed pollakisuria and urinary incontinence. PATIENTS AND METHODS: We investigated 10 postmenopausal women, age 54-83 years, with pollakisuria and urinary incontinence but did not show distinct urological and/or neurological abnormalities. In this study, estradiol transdermal therapeutic system ( Estraderm TTS 2 mg) alone were administrated for total of 8-week and this is observational, not randomized, blinded or controlled. A clinical evaluation were performed two times at before and after administration. RESULTS: In seven eligible cases, the severity of urinary incontinence was graded down in almost of them and the therapeutic effect on urinary incontinence was evaluated as "very effective" in 3 cases, "improved" in 2, "slightly improved" in 1 and "no change" in 1, respectively. In three eligible cases, the severity of pollakisuria was no change in all of them. CONCLUSION:
|
Authors | S Matsumoto, T Sugiyama, T Hanai, N Ohnishi, Y C Park, T Kurita |
Journal | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
(Nihon Hinyokika Gakkai Zasshi)
Vol. 91
Issue 5
Pg. 501-5
(May 2000)
ISSN: 0021-5287 [Print] Japan |
PMID | 10853331
(Publication Type: Clinical Trial, English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Administration, Cutaneous
- Aged
- Aged, 80 and over
- Estradiol
(administration & dosage)
- Estrogen Replacement Therapy
- Female
- Humans
- Middle Aged
- Postmenopause
- Urinary Incontinence
(drug therapy)
|